Researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London have identified a range of weight loss behaviours which are not included in current assessment criteria for eating disorders. These gaps may lead to missed or incorrect eating disorder diagnoses and treatment plans.
By
NIHR Maudsley BRC at 18 Jun 2025
Switching from one selective serotonin reuptake inhibitor (SSRI) to another antidepressant could be used to measure antidepressant non-response, according to new research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London.
By
NIHR Maudsley BRC at 28 May 2025
New research from King’s College London has found that ubrogepant – a drug used to manage migraine attacks – can effectively reduce the non-headache related symptoms when taken one to six hours prior to a migraine headache beginning.
By
NIHR Maudsley BRC at 14 May 2025
New research from the MIROCALS (Modifying Immune Responses and Outcomes in ALS) clinical trial has found that low-dose interleukin-2 (IL2LD) is both safe and effective for use on people with Motor Neurone Disease (MND), also known as amyotrophic lateral sclerosis (ALS) compared to placebo.
By
NIHR Maudsley BRC at 12 May 2025
An artificial intelligence (AI) model is being trained on a set of NHS data for 57 million people in England, from which personal information has been stripped away. The pilot study is being run by researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London and University College London (UCL). The model could transform patient care, identifying opportunities where early interventions might significantly improve or save lives.
By
NIHR Maudsley BRC at 7 May 2025